Jiangsu Favored Nanotechnology Co. Ltd. A
Jiangsu Favored Nanotechnology Co., Ltd engages in the research and development, and preparation of nanofilms worldwide. It offers plasma-enhanced chemical vapor deposition (PECVD) equipment, processes, and materials for smartphones and tablets, automotive electronics, audio and wearables, and other electronics. Jiangsu Favored Nanotechnology Co., Ltd was founded in 2016 and is based in Wuxi, Chi… Read more
Jiangsu Favored Nanotechnology Co. Ltd. A (688371) - Total Liabilities
Latest total liabilities as of June 2025: CN¥108.65 Million CNY
Based on the latest financial reports, Jiangsu Favored Nanotechnology Co. Ltd. A (688371) has total liabilities worth CN¥108.65 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangsu Favored Nanotechnology Co. Ltd. A - Total Liabilities Trend (2020–2024)
This chart illustrates how Jiangsu Favored Nanotechnology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jiangsu Favored Nanotechnology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Jiangsu Favored Nanotechnology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Phuoc Hoa Rubber JSC
VN:PHR
|
Vietnam | ₫1.90 Trillion |
|
Shenzhen Manst Technology Co. Ltd. A
SHE:301325
|
China | CN¥1.70 Billion |
|
PT Citra Marga Nusaphala Persada Tbk
F:J7K
|
Germany | €9.07 Trillion |
|
Shanghai HIUV New Materials Co Ltd
SHG:688680
|
China | CN¥1.48 Billion |
|
Birla Corporation Limited
NSE:BIRLACORPN
|
India | ₹69.73 Billion |
|
Angel Studios, Inc.
NYSE:ANGX
|
USA | $159.83 Million |
|
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
|
USA | $23.01 Million |
|
Wuhan Kotei Informatics Co.Ltd.
SHE:301221
|
China | CN¥183.25 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Jiangsu Favored Nanotechnology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Favored Nanotechnology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Favored Nanotechnology Co. Ltd. A (2020–2024)
The table below shows the annual total liabilities of Jiangsu Favored Nanotechnology Co. Ltd. A from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥125.03 Million | -9.24% |
| 2023-12-31 | CN¥137.75 Million | +27.97% |
| 2022-12-31 | CN¥107.64 Million | -61.30% |
| 2021-12-31 | CN¥278.15 Million | +162.57% |
| 2020-12-31 | CN¥105.93 Million | -- |